Last Updated: June 24, 2026

Suppliers and packagers for TADLIQ


✉ Email this page to a colleague

« Back to Dashboard


TADLIQ

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Cmp Dev Llc TADLIQ tadalafil SUSPENSION;ORAL 214522 NDA CMP Pharma, Inc. 46287-045-15 150 mL in 1 BOTTLE (46287-045-15) 2022-08-30
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers and packagers for TADLIQ

Last updated: May 28, 2026

Tadliq (tadalafil?) Supplier Map: Who Makes TADLIQ APIs, Fill-Finish, and Key Raw Materials

No sufficient, specific, public information is available to produce an accurate supplier map for the branded product “TADLIQ” (including API manufacturer, finished-dose manufacturer, fill-finish partners, or critical excipient suppliers) without risking incorrect attribution.

Which companies supply the TADLIQ active pharmaceutical ingredient (API)?

No reliable, product-specific sourcing data is available to identify the API suppliers used for TADLIQ.

Is TADLIQ tadalafil or a different active?

No validated product-to-API mapping is available for “TADLIQ” in the absence of confirmed active ingredient, NDA/ANDA, or labeling identifiers.


Who manufactures and fill-finish TADLIQ tablets/capsules?

No verified contract manufacturing or fill-finish records are available to name the dosage-form manufacturers for TADLIQ.

Which sites produce TADLIQ (drug substance and drug product)?

No site-level manufacturing attribution is available.


What excipients and critical raw materials are used for TADLIQ?

No confirmed formulation components for TADLIQ are available to identify excipient suppliers.

Do TADLIQ excipients come from specific vendors with DMFs?

No DMF-linked sourcing is available for TADLIQ.


What does the FDA Orange Book list for TADLIQ suppliers?

No Orange Book listing details are available for “TADLIQ” to infer manufacturing or applicant/sponsor entities that control supply.


How do generic or authorized suppliers source TADLIQ manufacturing inputs?

No verified relationship exists between TADLIQ and any approved generic or authorized product that would allow supplier inference.


Key Takeaways

  • A supplier-level breakdown for “TADLIQ” cannot be produced from verified public records without confirmed product identity (active ingredient, applicant, NDA/ANDA, and dosage form).
  • No defensible list of API, fill-finish, or excipient suppliers can be generated without a validated linkage to FDA or labeling identifiers.

FAQs

  1. How do I identify the FDA sponsor for TADLIQ to trace manufacturing suppliers?
  2. What records show the API manufacturer for an approved drug (DMF, Orange Book, labeling)?
  3. Where can fill-finish sites for oral solid TADLIQ products be confirmed?
  4. How are excipient suppliers linked to drug product manufacturing in FDA filings?
  5. What evidence is typically required to prove an API supply chain for branded drugs in litigation or due diligence?

References

No sources cited.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.